NCT00005057View on ClinicalTrials.gov

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2000

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

adenovirus RSV-TK

DRUG

ganciclovir

Trial Locations (3)

20892

Clinical Genetherapy Branch, Bethesda

Metabolism Branch, Bethesda

77030

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Human Genome Research Institute (NHGRI)

NIH

NCT00005057 - Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma | Biotech Hunter | Biotech Hunter